LifeStance Health (LFST) Cash & Current Investments (2020 - 2026)

LifeStance Health (LFST) has 7 years of Cash & Current Investments data on file, last reported at $76.9 million in Q1 2026.

• Quarterly Cash & Current Investments fell 43.09% year-over-year to $76.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $76.9 million (down 43.09% YoY) and the FY2025 annual result came in at $175.5 million, up 43.68% from the prior year.
• Cash & Current Investments eased to $76.9 million in Q1 2026 per LFST's latest filing, from $175.5 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $175.5 million in Q4 2025 and bottomed at $34.4 million in Q3 2023.
• The 5-year median for Cash & Current Investments is $113.0 million (2022), against an average of $105.0 million.
• The widest annual swing landed in 2024, when Cash & Current Investments plunged 71.04%; it then soared 272.27% in 2025.
• Tracing LFST's Cash & Current Investments over 5 years: stood at $113.0 million in 2022, then slumped by 37.52% to $70.6 million in 2023, then surged by 72.96% to $122.2 million in 2024, then surged by 43.68% to $175.5 million in 2025, then tumbled by 56.17% to $76.9 million in 2026.
• Per Business Quant, the three latest LFST Cash & Current Investments figures stand at $76.9 million (Q1 2026), $175.5 million (Q4 2025), and $141.8 million (Q3 2025).

Peer Comparison